LC3 Redistribution Tracks Autophagy in Humans
D
Dr. Guido Kroemer on Rhonda Patrick's podcast
Anti-AgingTesting
Story of claim
Dr. Kroemer describes using LC3 redistribution in white blood cells as a method to detect autophagy, requiring advanced cytofluorometry technology.
- Goal: To measure autophagy in humans via leukocytes.
- Proof: LC3 redistribution indicates autophagy, visible through immunofluorescence.
- Nuances:
- Requires advanced cytofluorometry technology.
- Standard devices measure fluorescence intensity, not distribution.
- Impact on Life: Allows researchers to measure autophagy in humans, potentially advancing clinical research.
Investments
- Price: Advanced technology may involve high costs.
- Time: Research and technology development required.
- Effort: Access to specialized equipment and expertise.
Risks
Technical complexity and cost may limit accessibility.
Alternatives
- Standard autophagy assays using simpler equipment
- Collaboration with specialized research facilities
Get Started 🚀
- Access to a lab with cytofluorometry capabilities.
- Training in advanced immunofluorescence techniques.
- Collaboration with clinical researchers.
Brogevity AI can make mistakes. Check important info.